// Biotech and Pharma Therapeutics
Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae
February 15, 2024 / Depression / Postpartum / Women’s Health / Sage Therapeutics
Why Communicating Data Results is Critical to Long-Term BioPharma Success
February 15, 2024 / IPO / Stakeholder Analysis / BioPharms
Roche-Backed Freenome Continues Industry’s Funding Rally with $254M Raise
February 15, 2024 / Roche / Cancer / Clinical Study
$4M Grant to Fund Development of Sleep Apnea Outcome Prediction Tools
February 12, 2024 / Sleep Apnea / AI / NIH / Mount Sinai
Firefly Bio Unveils $94M to Illuminate the Startup’s New Take on ADC Cancer Meds
February 15, 2024 / Firefly Bio / Startup / Cancer
// 4th Industrial Revolution
AI-enabled digital health tech catches mild cognitive impairment early
February 15, 2024 / AI / Digital Health / Health Tech / Dementia / Stroke
AI Chatbots Provide Inconsistent Musculoskeletal Health Information
February 14, 2024 / AI / ChatGPT / Google / BingAI
CMS clarifies rules for HIPAA compliance when texting patient data
February 12, 2024 / CMS / HIPAA / Patient Data / Healthcare
Phesi’s AI-driven Trial Accelerator platform contains over 100 million patients
February 12, 2024 / AI / Phesi / Clinical Trials
How a French health insurance unicorn plans to leverage AI to reach profitability
February 14, 2024 / Health Insurance / France / AI
// Business & Markets
As Catalent moves toward Novo buyout, its restructuring claimed 300 jobs last year
February 15, 2024 / Catalent / Layoffs / Job cuts / San Francisco
Aurinia to cut research after sale process fails to find a buyer
February 15, 2024 / Aurinia / Shareholders
Healthcare executives are investing in digital health tech without seeing an ROI
February 13, 2024 / Healthcare / Digital Health
Gilead to buy CymaBay in $4.3B deal for liver disease drug
February 12, 2024 / Gilead / Liver Disease / CymaBay
Genetic testing company Invitae files for bankruptcy
February 14, 2024 / Bankruptcy / Genetic testing / Invitae
// Legal & Regulatory
Pfizer quells 12 years of Lipitor antitrust litigation with $93M settlement
February 15, 2024 / Pfizer / Ranbaxy Laboratories / Sun Pharmaceutical / Lipitor
Hologic AI-powered cancer screening system wins FDA approval
February 9, 2024 / FDA Approval / AI / Cancer / Digital Cytology System
After FDA’s mixed approval decisions, Sage now says it’s ‘highly encouraged’ by Zurzuvae launch
February 14, 2024 / Sage Therapeutic / Biogen / Zuruvae / Postpartum Depression
FDA Reconsideration Leads to Approval of Takeda Drug for Rare Esophagus Disorder
February 12, 2024 / FDA / Drug Approval / Takeda Drug / Esophagus Disorder
Ipsen drug approved by FDA for early pancreatic cancer
February 14, 2024 / Novartis / Cancer / Acquisition / MorphoSys
// Research & Development
New study proves the efficacy of telepsychiatry for anxiety and depression
February 6, 2024 / New Study / Telepsychiatry / Anxiety / Depression / Mental Health
Positive results for MAIA’s SCLC treatment published in Nature Communications
February 14, 2024 / MAIA / SCLC / Biotech
Ampio’s last shot at success fizzles out in preclinical stage, leaving biotech to mull options
February 15, 2024 / Ampio Pharma / Osteoarthritis / Failed Trials / Biotech Graveyard
First UK patients receive experimental mRNA therapy for cancer in global trial
February 13, 2024 / UK Patients / mRNA / Cancer / Global Trial
Lyme disease cases rise, but largely due to a change in data collection
February 15, 2024 / Lyme Disease / Data / CDC
// Politics
Walton, Soros Family Offices Buy New Stakes in Biotech Firms
Februry 15, 2024 / Biotech / New Stakes
How the push to limit Chinese biotech could threaten U.S. edge
Februry 12, 2024 / Chinese Biotech / Bipartisan / Congress
U.S. Lawmakers Seek Investigation Against China’s WuXi AppTec
February 12, 2024 / Lawmakers / China / AppTech / Wuxi
Pharma Industry Faces Legal Setbacks as Medicare Drug Price Negotiations Begin
February 12, 2024 / Pharma / Drug Price / Medicare
White House wins in first Medicare negotiation legal ruling
February 14, 2024 / White House / Medicare